Background Biomarkers that reflect glioblastoma tumour activity and treatment response are
urgently needed to help guide clinical management, particularly for recurrent disease. As the …

Here, we describe a blood test for the detection of glial malignancies (GLI‐M) based on the
identification of circulating glial cells (CGCs). The test is highly specific for GLI‐M and can …

Neurological disorders are a diverse group of conditions that can significantly impact
individuals' quality of life. The maintenance of neural microenvironment homeostasis is …

Cancer is the most challenging health complication worldwide. Scientific society has tried to
decode its complications and is developing a smart solution for mankind. Extracellular …

Colorectal cancer (CRC) is the third most common cancer affecting people. The discovery of
new, non-invasive, specific, and sensitive molecular biomarkers for CRC may assist in the …

Direct and accurate analysis of low concentrations of tumor-derived exosomes in complex
biological samples is essential for non-invasive cancer diagnosis, but this remains …

Multiple sclerosis (MS) and glioblastoma (GBM) are CNS diseases in whose development
and progression immune privilege is intimately important, but in a relatively opposite …

Objective Glioblastoma (GBM) is one of the most aggressive brain tumors and often leads to
poor outcomes. Studies have indicated that glycan levels are significantly correlated with the …

US20240150849A1 - MicroRNAs AS BIOMAKERS FOR THE IN VITRO DIAGNOSIS OF
GLIOMA - Google Patents US20240150849A1 - MicroRNAs AS BIOMAKERS FOR THE IN …